Treace Medical Concepts (TMCI) Non Operating Investment Income (2022 - 2026)

Treace Medical Concepts (TMCI) has reported Non Operating Investment Income for 5 consecutive years, with -$26000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non Operating Investment Income fell 271.43% year-over-year to -$26000.0; the trailing twelve-month figure through Jun 2026 stood at -$102000.0 (down 234.21% YoY), and the FY2025 full-year result was -$25000.0, up 62.12% from the prior year.
• Non Operating Investment Income advanced to -$26000.0 in Q2 2026 per TMCI's latest filing, from -$98000.0 in the prior quarter.
• Across five years, Non Operating Investment Income topped out at $311000.0 in Q4 2023 and bottomed at -$163000.0 in Q2 2023.
• Historically, Non Operating Investment Income has averaged -$3466.7 across 5 years, with a median of -$27000.0 in 2022.
• The sharpest annual moves came in 2023 and 2026: Non Operating Investment Income jumped 1251.85% in 2023, then sank 271.43% in 2026.
• Over 5 years, Non Operating Investment Income stood at -$27000.0 in 2022, then surged by 1251.85% to $311000.0 in 2023, then slumped by 130.23% to -$94000.0 in 2024, then jumped by 88.3% to -$11000.0 in 2025, then tumbled by 136.36% to -$26000.0 in 2026.
• According to Business Quant data, Non Operating Investment Income over the past three periods registered -$26000.0, -$98000.0, and -$11000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.